Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
Holding SLXN?
Track your performance easily

Silexion Therapeutics (SLXN) Financial Statements

17 Followers

Silexion Therapeutics Financial Overview

Silexion Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.139; its P/E ratio is -1.93; Silexion Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ 1.42M--$ -237.00K$ -156.99K
EBITDA$ 1.43M--$ -237.00K$ -156.99K
Net Income Common Stockholders$ 1.37M--$ 292.58K$ 42.69K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.78M$ 4.59M$ 8.77M$ 202.33K$ 17.80K
Total Assets$ 3.58M$ 5.26M$ 9.33M$ 116.03M$ 115.40M
Total Debt$ 144.00K$ 171.00K$ 271.00K$ 1.00M$ 650.00K
Net Debt$ -2.64M$ -4.42M$ -8.49M$ 797.67K$ 632.20K
Total Liabilities$ 1.98M$ 2.25M$ 1.77M$ 1.03M$ 700.97K
Stockholders Equity$ -1.76M$ -419.00K$ 3.98M$ 114.99M$ 114.70M
Cash Flow-
Free Cash Flow$ -1.76M--$ 354.55K$ -57.86K
Operating Cash Flow$ -1.75M--$ 354.55K$ -57.86K
Investing Cash Flow$ -6.00K----
Financing Cash Flow---$ 350.00K$ 60.00K
Currency in USD

Silexion Therapeutics Earnings and Revenue History

Silexion Therapeutics Debt to Assets

Silexion Therapeutics Cash Flow

Silexion Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis